David Spiegel highlights a research article for Faculty of 1000 Medicine that supports aggressive treatment of depression in cancer patients to extend their life expectancy.
A study recommended by David Spiegel of Faculty of 1000 Medicine (
www.f1000medicine.com), looks at the relationship between depression care management and survival rates in older patients. He identifies it as “an important and well-conducted study of the effects of treatment of depression on survival in a primary care setting.”
A leading authority on mind-body interactions and professor of psychiatry and behavioural sciences at Stanford University, Spiegel evaluates the research published in the Annals of Internal Medicine, stressing the finding that “Comorbid depression shortens survival time with cancer, and intervention with medication and psychotherapy can therefore extend survival among cancer patients.”
The better survival rates were not seen in patients with depression and cardiovascular disease, only in those with cancer. Spiegel notes that this “is surprising given the well-known link between depression and poor cardiovascular disease outcome”.
He concludes, “Vigorous diagnosis and treatment programs for comorbid depression in cancer patients should, based on this study, extend survival time.”
Source: BioMed Central
Related stories:
Do antidepressants enhance immune function?
Infection with human immunodeficiency virus (HIV), which leads to acquired immunodeficiency syndrome (AIDS), is an epidemic of global concern. According to the most recent estimates, released in November 2007, by the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the World Health Organization (WHO), an estimated 33.2 million worldwide are living with HIV infection currently. Although the rates of infection appear to be decreasing, there are obviously immense implications for achieving improvements in HIV/AIDS treatment.
Heart failure patients may suffer similarly to advanced cancer patients
Heart failure outpatients have similar numbers of symptoms and levels of depression and spiritual well-being as patients with advanced lung and pancreatic cancer, researchers reported at the American Heart Association’s 9th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke.
Pancreatic cancer: The smaller the tumor, the better your chances, study shows
The odds of surviving cancer of the pancreas increase dramatically for patients whose tumors are smallest, according to a new study by researchers at Saint Louis University and the M.D. Anderson Cancer Center in Houston – the first study to specifically evaluate the link between tumor size and survival rates for one of the most common and deadly cancers.
Just 4 months of hormone therapy can delay prostate cancer growth by up to 8 years
Early, short course of hormonal therapy may allow patients to live longer
Alexandria, VA—Researchers report that just four months of hormonal therapy before and with standard external beam radiation therapy slowed cancer growth by as much as eight years—especially the development of bone metastases—and increased survival in older men with potentially aggressive prostate cancer. This “neoadjuvant” hormonal therapy may allow men most at risk of developing bone metastases avoid long-term hormonal therapy later on. Furthermore, the short-term hormonal therapy did not increase the risk of cardiovascular disease—a potential side effect of long-term hormonal therapy. The study is being published online January 2 in the Journal of Clinical Oncology (JCO).
Comorbidities common in bipolar disorder, may have genetic link
While the symptoms of bipolar disorder can be disabling on their own, most patients with the condition also are afflicted with a variety of other psychiatric, substance use and physical disorders. These comorbid conditions can complicate treatment and diagnosis.
Chernobyl: The true scale of the accident
20 years later a UN report provides definitive answers and ways to repair lives
A total of up to four thousand people could eventually die of radiation exposure from the Chernobyl nuclear power plant (NPP) accident nearly 20 years ago, an international team of more than 100 scientists has concluded.
Natural childbirth makes mothers more responsive to own baby-cry
A new study has found that mothers who delivered vaginally compared to caesarean section delivery (CSD) were significantly more responsive to the cry of their own baby, identified through MRI brain scans two to four weeks after delivery.
Women exposed to negative life events at greater risk of breast cancer
Happiness and optimism may play a role against breast cancer while adverse life events can increase the risk of developing the disease, according to a study by Professor Ronit Peled, at Ben-Gurion University of the Negev in Israel. An article on the study titled "Breast Cancer, Psychological Distress and Life Events among Young Women," was just published in the British journal
BMC Cancer (8:245, August 2008).